Risk of Adverse Outcomes for Older People with Dementia Prescribed Antipsychotic Medication: A Population Based e-Cohort Study
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Over recent years there has been growing evidence of increased risk of mortality associated with antipsychotic use in older people with dementia. Although this concern combined with limited evidence of efficacy has informed guidelines restricting antipsychotic prescription in this population, the use of antipsycotics remains common. Many published studies only report short-term outcomes, are restricted to examining mortality and stroke risk or have other limitations. The aim of this study was to assess adverse outcomes associated with the use of antipsychotics in older people living with dementia in Wales (UK). METHODS: This was a retrospective study of a population-based dementia cohort using the Welsh Secure Anonymised Information Linkage databank. The prior event rate ratio (PERR) was used to estimate the influence of exposure to antipsychotic medication on acute cardiac events, venous thromboembolism, stroke and hip fracture, and adjusted Cox proportional hazard models were used to compare all-cause mortality. RESULTS: A total of 10,339 people aged ≥65 years were identified with newly diagnosed dementia. After excluding those who did not meet the inclusion criteria, 9674 people remained in the main cohort of whom 3735 were exposed to antipsychotic medication. An increased risk of a venous thromboembolic episode [PERR 1.95, 95% confidence interval (CI) 1.83-2.0], stroke (PERR 1.41, 95% CI 1.4-1.46) and hip fracture (PERR 1.62, 95% CI 1.59-1.65) was associated with antipsychotic use. However, there was no long-term increased mortality in people exposed to antipsychotics (adjusted hazard ratio 1.06, 95% CI 0.99-1.13). CONCLUSIONS: The increase in adverse medical events supports guidelines restricting antipsychotic use in this population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schneider, L. S., Dagerman, K. S., & Insel, P. (2005) · JAMA · doi:10.1001/jama.294.15.1934 · Cited by 1,671 · cited 2×
“Our finding of a comparatively high mortality in the first 100 days after the initiation of antipsychotic treatment in older people with dementia is consistent with the body of literature describing the short-term increased mortality associated with antipsychotic use in dementia [11, 12, 33].”
ResultAssessment and management of behavioral and psychological symptoms of dementia
Kales, H. C., Gitlin, L. N., & Lyketsos, C. G. (2015) · BMJ · doi:10.1136/bmj.h369 · Cited by 1,247
Schneider, L. S., Dagerman, K., & Insel, P. S. (2006) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000200589.01396.6d · Cited by 903
The SAIL databank: linking multiple health and social care datasets
Lyons, R. A., Jones, K. H., John, G., Brooks, C. J., Verplancke, J.-P., Ford, D. V., Brown, G., & Leake, K. (2009) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-9-3 · Cited by 638 · cited 3×
“A large amount of preliminary work on anonymisation methodologies to protect privacy was undertaken to create the SAIL system [24, 25].”
BackgroundMethodSelf-citationAntipsychotic Drug Use and Mortality in Older Adults with Dementia
Gill, S. S., Bronskill, S. E., Normand, S.-L. T., Anderson, G. M., Sykora, K., Lam, K., Bell, C. M., Lee, P. E., Fischer, H. D., Herrmann, N., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-11-200706050-00006 · Cited by 624 · cited 2×
“Our finding of a comparatively high mortality in the first 100 days after the initiation of antipsychotic treatment in older people with dementia is consistent with the body of literature describing the short-term increased mortality associated with antipsychotic use in dementia [11, 12, 33].”
BackgroundResultQTc-interval abnormalities and psychotropic drug therapy in psychiatric patients
Reilly, J., Ayis, S., Ferrier, I., Jones, S., & Thomas, S. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02035-3 · Cited by 602 · cited 1×
“The risk of acute cardiac events as a consequence of antipsychotic use in older people with dementia has not been previously examined in detail [5, 6, 8], but there is an expectation of increased in risk based on drug trial data and the findings of electrocardiogram abnormalities in younger populations [38].”
Maher, A. R., Maglione, M., Bagley, S., Suttorp, M., Hu, J.-H., Ewing, B., Wang, Z., Timmer, M., Sultzer, D., & Shekelle, P. G. (2011) · JAMA · doi:10.1001/jama.2011.1360 · Cited by 558
Livingston, G., Kelly, L., Lewis-Holmes, E., Baio, G., Morris, S., Patel, N., Omar, R. Z., Katona, C., & Cooper, C. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.113.141119 · Cited by 426
Management of agitation and aggression associated with Alzheimer disease
Ballard, C. G., Gauthier, S., Cummings, J. L., Brodaty, H., Grossberg, G. T., Robert, P., & Lyketsos, C. G. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.39 · Cited by 404 · cited 1×
“These concerns are supported bymeta-analyses of randomised controlled trials (RCTs) [5, 7, 11] and a large U.”
Risk of Mortality Among Individual Antipsychotics in Patients With Dementia
Kales, H. C., Kim, H. M., Zivin, K., Valenstein, M., Seyfried, L. S., Chiang, C., Cunningham, F., Schneider, L. S., & Blow, F. C. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11030347 · Cited by 384
Neuroleptic drugs in dementia: benefits and harm
Ballard, C., & Howard, R. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1926 · Cited by 308 · cited 3×
“Although there are only limited effects on behavioural and psychological symptoms with antipsychotic medications in older people with dementia, they continue to be used despite concerns over their safety [5].”
BackgroundLopez, O. L., Becker, J. T., Chang, Y.-F., Sweet, R. A., Aizenstein, H., Snitz, B., Saxton, J., McDade, E., Kamboh, M. I., DeKosky, S. T., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12081046 · Cited by 129 · cited 4×
“The first factor is that other studies which have examined longer-term effects of antipsychotics have similarly found no increased risk [22, 23]; in particular, Lopez et al.”
BackgroundInfluentialRaivio, M. M., Laurila, J. V., Strandberg, T. E., Tilvis, R. S., & Pitkälä, K. H. (2007) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31802d0b00 · Cited by 99 · cited 2×
“Conventional antipsychotic agents have generally been found to be associated with a greater risk of mortality compared to newer atypical drugs [12, 17–19, 33, 42–45], but there are some exceptions [20, 22].”
BackgroundBrown, A., Kirichek, O., Balkwill, A., Reeves, G., Beral, V., Sudlow, C., Gallacher, J., & Green, J. (2016) · Emerging Themes in Epidemiology · doi:10.1186/s12982-016-0053-z · Cited by 78 · cited 1×
“The dementia Read codes used in our study are similar to those used in research based upon the Clinical Practice Research Datalink in England; they have been found to have positive predictive value of 80–90% [47] and have high levels of agreement with Hospital Episode Statistics data [48].”
MethodSimoni-Wastila, L., Ryder, P. T., Qian, J., Zuckerman, I. H., Shaffer, T., & Zhao, L. (2009) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31819b8936 · Cited by 63
Cited by
Ralph, S. J., & Espinet, A. J. (2018) · Journal of Alzheimer's Disease Reports · doi:10.3233/adr-170042 · Cited by 160
“Dennis et al., 2017 [40]Atypical 1687 France 16 French Memory Centres 534 Alzheimer’s Dementia patients, 102 new users All-cause Mortality in Alzheimer’s dementia 3.5-year follow-up Antipsychotics (typical and atypical) new use versus non-user control HR = 1.93; [1.15–3.25] Gardette et al., 2012…”
BackgroundInfluentialTargeting Behavioral Symptoms and Functional Decline in Dementia: A Randomized Clinical Trial
Gitlin, L. N., Arthur, P., Piersol, C., Hessels, V., Wu, S. S., Dai, Y., & Mann, W. C. (2018) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15194 · Cited by 119
“Off-label antipsychotic medications that are prescribed off label have risks, including stroke and mortality, that often outweigh their modest benefits.(7,8) Pharmacological treatments also do not address behaviors distressful to families (rejection of care).”
BackgroundSaragih, I. D., Tonapa, S. I., Porta, C. M., & Lee, B. (2022) · Journal of Nursing Scholarship · doi:10.1111/jnu.12797 · Cited by 37
Metadata
- Authors
- Dennis, M., Shine, L., John, A., Marchant, A., McGregor, J., Lyons, R. A., & Brophy, S.
- Venue
- Neurology and Therapy
- Published
- 2017-01-04
- Volume
- 6
- Issue
- 1
- Pages
- 57-77
- ISSN
- 2193-6536 (ISSN-L)
- 2193-8253
- OpenAlex
- W2570334379
- Cited by
- 54
- References
- 15
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.